Online citations, reference lists, and bibliographies.
← Back to Search

Treatment Patterns Among Patients With Malignant Pleural Mesothelioma: An Italian, Population‐based Nationwide Study

A. Trama, C. Proto, D. Signorelli, M. Garassino, G. Lo Russo, M. Ganzinelli, A. Prelaj, C. Mensi, Manuela Gangemi, V. Gennaro, E. Chellini, A. Caldarella, I. Angelillo, V. Ascoli, C. Pascucci, G. Tagliabue, R. Cusimano, F. Bella, F. Falcini, E. Merler, G. Masanotti, Antonio Ziino, M. Michiara, G. Gola, C. Storchi, L. Mangone, M. F. Vitale, C. Cirilli, R. Tumino, T. Scuderi, A. C. Fanetti, Silvano Piffer, M. Tiseo, G. Gatta, L. Botta
Published 2020 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Malignant pleural mesothelioma (MPM) is a rare cancer with a poor prognosis. Centralization of rare cancer in dedicated centers is recommended to ensure expertise, multidisciplinarity and access to innovation. In Italy, expert centers for MPM have not been identified in all regions. We aimed to describe the treatment patterns among MPM patients across different Italian regions and to identify factors associated with the treatment patterns across the regions.
This paper references
10.1016/0169-5002(95)00508-0
A proposed new international TNM staging system for malignant pleural mesothelioma from the International Mesothelioma Interest Group.
V. Rusch (1996)
Pleural mesothelioma incidence in Europe : Evidence of some deceleration in the increasing . ( Published erratum appears in Cancer Causes Control 2004 ; 15 : 103 . )
F Montanaro
Malignant pleural mesothelioma: ESMO clinical practice guidelines
P Baas (2015)
10.1016/j.critrevonc.2016.05.004
The Third Italian Consensus Conference for Malignant Pleural Mesothelioma: State of the art and recommendations.
S. Novello (2016)
10.1371/journal.pone.0145039
Determinants of Survival in Malignant Pleural Mesothelioma: A Surveillance, Epidemiology, and End Results (SEER) Study of 14,228 Patients
E. Taioli (2015)
10.1700/1088.11932
Effects of combined therapies on the survival of pleural mesothelioma patients treated in Brescia, 1982-2006.
P. Barbieri (2012)
10.1159/000486578
Management and Survival of Pleural Mesothelioma: A Record Linkage Study
G. Carioli (2018)
10.1016/j.athoracsur.2016.06.069
A Multicenter Study of Volumetric Computed Tomography for Staging Malignant Pleural Mesothelioma.
V. Rusch (2016)
10.1097/JTO.0b013e3181f1903e
Frequency of Use and Predictors of Cancer-Directed Surgery in the Management of Malignant Pleural Mesothelioma in a Community-Based (Surveillance, Epidemiology, and End Results [SEER]) Population
R. Flores (2010)
10.1016/j.lungcan.2015.05.014
Treatment patterns and survival analysis in 9014 patients with malignant pleural mesothelioma from Belgium, the Netherlands and England.
R. Damhuis (2015)
10.1002/ijc.23874
Survival of pleural malignant mesothelioma in Italy: A population‐based study
F. Montanaro (2009)
10.1016/S0959-8049(03)00233-8
Analysis of survival of mesothelioma cases in the Italian register (ReNaM).
A. Marinaccio (2003)
Treatment patterns and 1668 Thoracic Cancer
RA Damhuis (2020)
10.2147/CLEP.S105396
Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)–Medicare investigation of treatment patterns and overall survival
J. Beebe-Dimmer (2016)
Pleural mesothelioma incidence in Europe: Evidence of some deceleration in the increasing. (Published erratum appears in Cancer Causes Control
F Montanaro (2004)
10.1200/JCO.2012.30.15_SUPPL.10053
The Italian Rare Cancer Network.
R. Sanfilippo (2012)
10.1378/CHEST.108.4.1122
A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group.
V. Rusch (1995)
10.1038/bjc.2014.312
Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter survey
G. Ceresoli (2014)
10.1097/COC.0b013e3181d31f02
Expert Opinions of the First Italian Consensus Conference on the Management of Malignant Pleural Mesothelioma
C. Pinto (2011)
Italian population by region and age
10.1016/j.ejca.2010.02.022
EORTC elderly task force position paper: approach to the older cancer patient.
A. Pallis (2010)
10.1016/j.ejso.2018.03.030
Networking in rare cancers: What was done, what's next.
A. Frezza (2019)
The Italian rare cancer
R Sanfilippo (2012)
10.1016/j.ctrv.2012.11.004
Second Italian consensus conference on malignant pleural mesothelioma: state of the art and recommendations.
C. Pinto (2013)
10.1016/j.lungcan.2017.08.009
Patterns of care and survival among patients with malignant mesothelioma in the United States.
L. Enewold (2017)
10.1016/S1470-2045(17)30445-X
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study.
G. Gatta (2017)
10.1023/A:1026300619747
Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends
F. Montanaro (2004)
10.1038/sj.bjc.6601638
The Mesothelioma epidemic in Western Europe: an update
C. Pelucchi (2004)
10.1016/S1470-2045(11)70149-8
Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study
T. Treasure (2011)
10.2478/v10019-012-0032-0
Improved survival after introduction of chemotherapy for malignant pleural mesothelioma in Slovenia: Population-based survey of 444 patients
V. Kovač (2012)
10.1136/oemed-2016-103652
Incidence of mesothelioma in Lombardy, Italy: exposure to asbestos, time patterns and future projections
C. Mensi (2016)
10.1089/jwh.1.1999.8.1119
Clinical practice guidelines.
J. Wootton (1999)



Semantic Scholar Logo Some data provided by SemanticScholar